How Real-World Adherence Is Shaping Preventive Migraine Treatment
Alexandria May, PharmD, BCPS
Jessica Ailani, MD, FAHS, FAAN, FANA
When “Mild” Matters Most: Closing Clinical Gaps in Early Symptomatic AD
Multiple dates available
Vagus Nerve Stimulation Shows Short-Term Benefit in Chronic Migraine Trial
Recognizing TK2d: Key Clinical Signs and Diagnostic Protocols
Kaitlin Batley, MD
When Movements Steal Lives: TD Burden, Stigma, and the Therapeutic Alliance
Tracy Hicks, DNP, MBA
Subtle vs Syndromic: Distinguishing TD from Other DIMDs in the Neuro Clinic
Melissa Moody, MD
The 15-Minute Med Check: Making AIMS and TD Screening Routine in Psychiatry
Shared Decisions, Real Patients: Patient-Centered TD and Antipsychotic Strategies
FXIa Remix! Keeping the Flow Without Missing a Beat
Mike Sharma, MD, MSc, FRCPC
Ashkan Shoamanesh, MD
Brian Mac Grory, MB, BCh BAO, MRCP, FAHA, FANA
Emerging Focus in NAION: Sharpening Diagnostic Precision for Tomorrow’s Treatments
Prem S. Subramanian, MD, PhD
Andrew G. Lee, MD
Valerie Biousse, MD
Tau Therapies and Clinical Translation: Mechanistic Approaches
Dani Cabral, MD
Mohammed Q. Al-Sabbagh, MD
NPS Psychosis: Circuits, Treatment, and New Hope
Beyond Cognition: Managing Alzheimer’s as an Integrated Neurodegenerative–Neuropsychiatric Syndrome
Marwan Sabbagh, MD, FAAN
NPS Agitation: Evidence and Emerging Mechanisms of Management
Microglia Drive Neurodegeneration in Friedreich’s Ataxia
Ryan Quigley
Is Friedreich’s Ataxia Developmental or Degenerative?
Arnulf Koeppen, MD
Loading...
We're glad to see you're enjoying Global Neurology Academy… but how about a more personalized experience?
Press cancel to remain on Global Neurology Academy. Press the link below or the continue button to keep going.